The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis

Journal of Clinical Immunology

Volumn 19, Issue 4, 1999, Pages 215-222

  Muiño, Juan C ^a   Juárez, Claudio P ^b   Luna, José D ^b   Castro, Carlos C ^a   Wolff, Enrique G ^a   Ferrero, Mercedes ^a   Romero Piffiguer, Marta D ^a  

^a Misericordia Hospital ^*  (Argentina)

^b Fundacion VER   (Argentina)

Author keywords

Autoimmune uveitis; IgG and IgE isotypes; Infectious uveitis; Retinal S antigen; sCD23

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RETINA S ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHORIORETINOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UVEITIS;

ADULT; ANTIBODY SPECIFICITY; ARRESTIN; AUTOANTIBODIES; AUTOIMMUNE DISEASES; EYE INFECTIONS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, IGE; SOLUBILITY; TOXOPLASMOSIS, OCULAR; UVEITIS;

EID: 0032869354     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020516029883     Document Type: Article

References (45)

1. Palestine AG: Autoimmune uveitis. In Current Therapy in Allergy, Immunology, Rheumatology, LM Lichtenstein, AS Fauci (eds). Toronto/St. Louis, Decker-Mosby, 1985/1986, pp 204-206
2. st ed. Chicago, Year Book Medical, 1989, pp 21-52
3. Friedlander M: Ocular Allergy: In Allergy Principles and Practice, E Middleton, ChE Reed, EF Ellis, NF Adkinson, JW Yunginger, WW Busse (eds). St. Louis. Mosby, 1993. pp 1649-1660
4. Irani AM; Ocular mast cells and mediators. Immunol Allergy Clin North Am 17:1-18, 1997
5. Wacker WB, Donoso LA, Kaslow CM, Yankeelov JA, Organiciak DT: Experimental autoimmune uveitis. Isolation, characterization and localization ofa soluble uveitopathogenic antigen from bovine retina. J Immunol 119:1949-1958, 1977
6. Donoso LA, Gregerson DS, Smith L, Robertson S, Knospe V, Vrabed T, Kaslow CM: S antigen: Preparation and characterization of site specific monoclonal antibodies. Curr Eye Res 9:343-355, 1990
7. nd ed. St. Louis, Mosby, 1996, pp 3-47
8. Roit IM. The T cell priming hurdle in autoimmune disease and tumor immunity. Immunologist 2:42-46, 1994
9. Romagnani S. Del Prete GF, Maggi E, Ricci MT: Th1 and Th2 cells and their role in disease. ACI News 5:19-22, 1993
10. Maliszewski CR, Park LS: The interleukin-4 receptor: Potential therapeutic applications in the allergic response. ACI News 2:86-90, 1990
11. Kelso A: Th1 and Th2 subsets: paradigms lost? Immunol Today 16:374-379, 1995
12. Celis E: T Helper cells and autoantibodies in autoimmune disease. Immunologist 1:126-130, 1993
13. Muraille E, Leo O: Revisting the Th1/Th2 paradigm. Scand J Immunol 47:1-9, 1998
14. Adorini L, Trembleau S: Autoimmune diabetes as a test for Th1/Th2 paradigm. Immunologist 6:146-150, 1998
15. Gordon J: CD 23 novel disease marker with a split personality. Clin Exp Immunol 86:356-359, 1991
16. Gordon J, Katira A, Flores Romo L, Jhonson GD: Membrane CD 23 a target for feedback regulation on IgE synthesis. Inmunologia 11:37-43, 1992
17. Bansal A, Haeny MR, Cochrane S, Pumphrey RSH, Green LM, Bhavnani M, Wilson PB: Serum soluble CD23 in patients with hypogammaglobulinemia. Clin Exp Immunol 97:239-241. 1994
18. Gordon J: B cell signaling via the C-type lectins CD 23 and CD72. Immunol Today 15:411-417, 1994
19. Mudde GC, Hansel TT, Reijsen FC, Osterhoff BF, Bruijnzeel Koomen CAFM: IgE: An immunoglobulin specialized in antigen capture? Immunol Today 11:440-443, 1990
20. Bonnefoy JY, Zyrber Ch P, Henchoz SL, Gauchat JF, Aubry JP, Graber P: A new role for CD23 in inflammation. Immunol Today 17:418-420, 1996
21. Bansal A, Roberts T, Hay EM, Kay R, Pumphrey RSH, Wilson PB: Soluble CD 23 levels are elevated in the serum of patients with primary Sjögren syndrome and systemic lupus erythematosus. Clin Exp Immunol 89:452-455, 1992
22. Muiño JC, Kahn A, Wolff EG, Castro CC, Gagliardi JR, Ferrero M, Romero M: The highs CD23 and IgE serum levels in sera of the SLE patients. J Allergy Clin Immunol 101(1.part 2);S121, 1998
23. Muiño JC, Castro CC, Gagliardi JR, Wolff EG, Gómez RM, Guglielmone II, Alé AM, Ferrero M, Romero MD: Regulación de la respuesta inflamatoria de la aspergilosis alérgica broncopulmonar por antfgenos Clase III del complejo mayor de histocompatibilidad (C4, C2, FB), CD 23 soluble y fallas de la fagocitosis. Rev Med Córdoba 85:2-12, 1997
24. Dorey O, Cozette J, Faure JO: A simple and rapid method for isolation of retinal S antigen. Ophthalm Rev 14:249-255, 1982
25. Nieto A, Carbonetto CA; Enzimoinmuno-ensayo. In Inmunología e Inmunoquímica, Margni RA (ed). Buenos Aires, Panamericana, 1989, pp 571-586
26. Dugas B, Mossalay MD, Damais Ch, Kolb JP: Nitric oxide production by human monocytes: Evidence for role of CD 23. Immunol Today 574-589, 1995
27. McMenamin PG, Crewe J, Istra A: Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein induced uveitis. (EMIU). Ocular Immunol Inflam 5:223-233, 1997
28. Chateris DG, Lightman SL: In vivo lymphokine production in experimental uveoretinitis. Immunology 78:387-392, 1993
29. Liversidge J, Dick A, Cheng YF, Scott GB, Forester JV: Retinal antigen specific lymphoecytes, TCR gamma-delta T cells and CD5+ B cell cultures from vitreous in acute sympathic ophtalmitis. Autoimmunity 15:2257-2266, 1993
30. Keegan AD, Ryan JJ, Paul WE: IL 4 regulates growth and differentiation by distinct mechanisms. Immunologist 4:194-198, 1996
31. Lane P, Flynn S, Walker L, Backer T. Gulbrnason-Judge A: CD4 cytokine differentiation. Who or what decides. Immunologist 6:182-185, 1998
32. Kauffmann SHE: Immunity to intracellular bacterias and protozoa. Immunologist 3:221-225, 1995
33. Freij BJ, Wiedbrauk DL Sever JL: Immunologist assessment of infectious diseases. Immunol Allergy Clin North Am 14:451-474, 1994
34. Thorsby E: HLA associated disease susceptibility. Which genes are primary involved? Immunologist 3:51-58, 1995
35. Lamont AE, Adorini L: IL 12: A key cytokine in immune regulation. Immunol Today 17:214 217, 1996
36. Kumar V, Sercarz E, Adorini I: Regulatory mechanisms in organ-specific autoimmunity, Immunologist 6:161-166, 1998
37. Theofilopoulos AN: The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today 16:90-98, 1995
38. Zinkernagel RM, Kelly J: How antigen influences immunity. Immunologist 5:114-120, 1997
39. Mitchinson A: Autoimmune disease. Immunologist 5:32-33, 1997
40. Kruibeek AM: Tolerance. Immunologist 3:176-184, 1995
41. Stockinger B, Zal T, Volkmann A, Fossati G, Barthlot T: Induction of tolerance or (auto)immunity in MHC class II restricted T cells. Immunologist 6:102-105, 1998
42. + T cells, positive selection and surveillance of autoantibody production. Immunologist 5:121-126, 1997
43. Withcup SM, Nussenblatt RB: Immunologic ocular disease. In Clinical Immunology. Principle and Practice, RR Rich, TA Fleisher, BP Schwartz, WT Shearer, W Strober (eds), St. Louis, Mosby, 1996, pp 1579-1591
44. Weiner HL, Friedman A, Miller A, Khoury SJ, Sabbagh AA, Santos L, Sayegh M, Nussenblat RB, Trentham DE, Hafler DA: Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of auto-antigens. Annu Rev Immunol 12:809-837, 1994
45. Röcken M, Racke M, Shevach EM: IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231, 1996